resveratrol has been researched along with Diabetes Mellitus in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (5.88) | 29.6817 |
| 2010's | 40 (58.82) | 24.3611 |
| 2020's | 24 (35.29) | 2.80 |
| Authors | Studies |
|---|---|
| Aissopou, E; Chatziralli, I; Chatzirallis, A; Dimitriou, E; Kazantzis, D; Theodossiadis, G; Theodossiadis, P | 1 |
| Aarabi, MH; Asemi, Z; Mafi, A; Salami, M; Salami, R; Vakili, O | 1 |
| Bi, W; Du, H; Lei, T; Xiao, Z; Yang, Y; Zhang, X | 1 |
| Bao, C; Feng, J; Tan, Y; Xiao, Y | 1 |
| Chen, YY; Cheng, PW; Ho, CY; Sun, GC; Tseng, CJ; Wu, TT; Yeh, TC | 1 |
| Kushwaha, P; Pandey, S; Shaif, M; Shamim, A | 1 |
| Chen, L; Chen, S; Jiang, H; Li, B | 1 |
| Cheng, S; Feng, Y; He, H; Huang, Z; Li, Y; Pan, S; Pathak, JL; Wang, L | 1 |
| Bryl, A; Falkowski, M; Mrugacz, M; Zorena, K | 1 |
| Kang, W; Shen, S; Wang, T; Wei, J | 1 |
| Moon, DO | 1 |
| Cao, Y; Deng, Z; Liu, C; Sun, W; Yan, M; Yin, X; Zhang, M; Zhou, Z; Zhu, X | 1 |
| Bi, M; Qin, Y; Wang, L; Zhang, J | 1 |
| Cai, X; Gao, S; Gao, Y; Huang, H; Lei, X; Lin, Y; Shi, S; Wang, Y; Yao, Y; Zhang, G; Zhao, Y | 1 |
| Huang, DD; Jiang, Y; Shi, G; Yao, C; Zhu, C | 1 |
| Alizadeh, M; Foroumandi, E; Hajizadeh-Sharafabad, F; Kheirouri, S; Maleki, V | 1 |
| Biray Avcı, Ç; Çetinkalp, Ş; Doğan, F; Eroğlu, İ; Gökçe, EH; Gündüz, C; Özer, Ö; Şimşir, I; Tuncay Tanrıverdi, S; Utku, T | 1 |
| Gulyayev, A; Krivykh, E; Masoud, AR; Nurgozhin, T; Saliev, T; Sergazy, S; Umbayev, B; Yessenkyzy, A; Zhanaliyeva, M | 1 |
| Aly, HAA | 1 |
| Eseberri, I; Lasa, A; Laurens, C; Louche, K; Miranda, J; Moro, C; Portillo, MP | 1 |
| Dej-Adisai, S; Heemman, A; Hong, BN; Jeong, SY; Kang, TH; Kim, NW; Nam, YH; Nuankaew, W; Shim, JH; Wattanapiromsakul, C; Yasmin, T | 1 |
| Becer, E; Hoca, M; Vatansever, HS | 1 |
| Chen, H; Zheng, T | 1 |
| Bobermin, LD; Leipnitz, G; Quincozes-Santos, A; Schmitz, I; Sovrani, V | 1 |
| Chen, J; Gao, K; Jia, C; Murtaza, G; Tian, G; Wahab, A; Zhang, F | 1 |
| Arslan, AKK; Bishayee, A; Öztürk, E; Yerer, MB | 1 |
| Babu, PVA; Jalili, T; Qian, Y; Symons, JD | 1 |
| Awad, E; Othman, EM; Stopper, H | 1 |
| Akter, J; An, HJ; Chun, P; Chung, HY; Jeong, HO; Kim, DH; Kim, MJ; Kim, SJ; Lee, B; Lee, EK; Lee, HJ; Moon, HR; Moon, KM; Ullah, S; Yang, J | 1 |
| Aktaş, Y; Karatoprak, GŞ; Yücel, Ç | 1 |
| Arcanjo, NMO; Estévez, M; Luna, C; Madruga, MS | 1 |
| Kulashekar, M; Peuler, JD; Stom, SM | 1 |
| Górski, K; Malinowski, B; Pawlak-Osińska, K; Rewerski, S; Socha, M; Walczak, M; Wiciński, M; Wódkiewicz, E | 1 |
| Bhatnagar, A; Pannu, N | 1 |
| Gupta, SC; Kaschula, CH; Maiti, P; Rai, V; Singh, AP; Singh, R; Verma, SS | 1 |
| Jayamurthy, P; Jithin, MM; Kumar, NA; Lekshmy, K; Prabha, B; Radhakrishnan, KV; Sasikumar, P; Shibi, IG; Sini, S; Sivan, VV | 1 |
| Jeong, GH; Kim, TH; Park, EK | 1 |
| Arkell, AM; Beaudoin, MS; Holloway, GP; Simpson, JA; Snook, LA; Wright, DC | 1 |
| Bartolo, M; Carrizzo, A; Damato, A; Forte, M; Maciag, A; Puca, AA; Salzano, F; Trimarco, V; Vecchione, C | 1 |
| Giri, PR; Joshi, PA; Majumdar, AS | 1 |
| Abdollahi, M; Saeidnia, S | 1 |
| Guo, R; Li, W; Liu, B; Wang, K; Xu, Y; Zhou, S | 1 |
| Giri, PR; Majumdar, AS; Pai, SA | 1 |
| Lou, XD; Skog, S; Sun, J; Wang, HD; Xia, SJ | 1 |
| Evangelopoulos, A; Kazazis, C; Vallianou, NG | 1 |
| Carpene, C; Carpene, MA; Deleruyelle, S; Gomez-Zorita, S | 1 |
| Howes, MJ; Simmonds, MS | 1 |
| Szkudelska, K; Szkudelski, T | 3 |
| Dyck, JR; Hamza, SM; Sung, MM | 1 |
| Baur, JA; Breen, DM; Côté, CD; Daljeet, M; Duca, FA; Filippi, BM; Lam, TK; Rasmussen, BA; Zadeh-Tahmasebi, M | 1 |
| Bagul, PK; Banerjee, SK | 1 |
| Li, P; Lin, N; Liu, A; Zhang, L; Zhou, C | 1 |
| Kamaleddin, MA | 1 |
| Adeyanju, AA; Oguntibeju, OO; Oyenihi, AB; Oyenihi, OR | 1 |
| Jiang, WJ | 1 |
| Maulik, N; Penumathsa, SV | 1 |
| Ho, CT; Huang, D; Lv, L; Sang, S; Shao, X; Wang, L | 1 |
| Campbell, RK; Gates, BJ; Levien, TL; Robinson, JD; Sonnett, TE | 1 |
| Luo, Z; Ma, L; Si, L; Xu, Q; Yang, Q; Zhang, Y | 1 |
| Resmi, H | 1 |
| Baur, JA; Hausenblas, HA; Smoliga, JM | 1 |
| Ebersole, J; González, O; Novak, MJ; Tobia, C | 1 |
| Bruedigam, C; Chiba, H; Eijken, M; Koedam, M; van Leeuwen, JP | 1 |
| Das, DK; Fujitaka, K; Iwasaka, T; Iwasaki, M; Jo, F; Jo, H; Nishikawa, M; Nomura, E; Otani, H | 1 |
| Burant, CF; Subauste, AR | 1 |
| Shankar, S; Singh, G; Srivastava, RK | 1 |
34 review(s) available for resveratrol and Diabetes Mellitus
| Article | Year |
|---|---|
Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling.
Topics: Antioxidants; Diabetes Mellitus; Diabetic Nephropathies; Humans; Kidney; Oxidative Stress; Polyphenols; Resveratrol | 2022 |
The combined therapy of mesenchymal stem cell transplantation and resveratrol for diabetes: Future applications and challenges.
Topics: Diabetes Mellitus; Fibrosis; Glucose; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Resveratrol | 2022 |
A Mediterranean Diet May Be Protective in the Development of Diabetic Retinopathy.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Retinopathy; Diet, Mediterranean; Fabaceae; Olive Oil; Polyphenols; Resveratrol; Vegetables | 2023 |
A comprehensive review of the effects of resveratrol on glucose metabolism: unveiling the molecular pathways and therapeutic potential in diabetes management.
Topics: Adipocytes; Carbohydrate Metabolism; Diabetes Mellitus; Glucose; Humans; Resveratrol | 2023 |
The protective role of resveratrol in diabetic wound healing.
Topics: Diabetes Mellitus; Humans; Inflammation; Resveratrol; Wound Healing | 2023 |
A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications.
Topics: Animals; Blood Glucose; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Glucose; Humans; Oxidative Stress; Resveratrol | 2020 |
The effect of resveratrol on advanced glycation end products in diabetes mellitus: a systematic review.
Topics: Animals; Antioxidants; Diabetes Mellitus; Glycation End Products, Advanced; Humans; Oxidative Stress; Resveratrol | 2022 |
Polyphenols as Caloric-Restriction Mimetics and Autophagy Inducers in Aging Research.
Topics: Aging; Animals; Apoptosis; Autophagy; Caloric Restriction; Cellular Senescence; Diabetes Mellitus; Dietary Supplements; Healthy Aging; Humans; Longevity; Mitochondria; Neoplasms; Neurodegenerative Diseases; Polyphenols; Protein Aggregation, Pathological; Resveratrol; Sirtuin 1 | 2020 |
The role of resveratrol in diabetes and obesity associated with insulin resistance.
Topics: Animals; Diabetes Mellitus; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Obesity; Resveratrol; Stilbenes | 2023 |
Potential Glioprotective Strategies Against Diabetes-Induced Brain Toxicity.
Topics: Animals; Astrocytes; Brain; Diabetes Mellitus; Glucose; Humans; Isoflavones; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Thioctic Acid | 2021 |
Significance of Resveratrol in Clinical Management of Chronic Diseases.
Topics: Aging; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Humans; Neoplasms; Obesity; Polyphenols; Resveratrol; Stilbenes | 2017 |
Resveratrol and diabetes: A critical review of clinical studies.
Topics: Animals; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Humans; Hypoglycemic Agents; Resveratrol; Stilbenes | 2017 |
Resveratrol's Potential in the Adjunctive Management of Cardiovascular Disease, Obesity, Diabetes, Alzheimer Disease, and Cancer.
Topics: Alzheimer Disease; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus; Humans; Obesity; Resveratrol | 2018 |
Beneficial Effects of Resveratrol Administration-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions.
Topics: Animals; Cardiovascular Diseases; Cerebrovascular Circulation; Cyclic AMP; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Cytokines; Diabetes Mellitus; Disease Models, Animal; Humans; Inflammation; Platelet Aggregation Inhibitors; Polyphenols; Reactive Oxygen Species; Resveratrol; Sirtuin 1 | 2018 |
Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biological Availability; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus; Drug Delivery Systems; Humans; Neoplasms; Obesity; Protein Biosynthesis; Resveratrol | 2019 |
Health benefits of resveratrol: Evidence from clinical studies.
Topics: Animals; Antioxidants; Diabetes Mellitus; Humans; Metabolic Syndrome; Neoplasms; Obesity; Resveratrol | 2019 |
Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases.
Topics: Antioxidants; Biological Availability; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Diabetes Mellitus; Humans; Metabolic Diseases; Oxidation-Reduction; Oxidative Stress; Resveratrol; Stilbenes | 2013 |
Toxicological and pharmacological concerns on oxidative stress and related diseases.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Benzopyrans; Carbazoles; Carvedilol; Diabetes Mellitus; Disease Models, Animal; Ethanolamines; Humans; Hydrogen Peroxide; Inflammatory Bowel Diseases; Nebivolol; Neoplasms; Neurodegenerative Diseases; Osteoporosis; Oxidative Stress; Propanolamines; Reactive Oxygen Species; Resveratrol; Stilbenes; Vascular Diseases | 2013 |
Resveratrol and diabetes.
Topics: Animals; Diabetes Mellitus; Humans; Hypoglycemic Agents; Plant Extracts; Resveratrol; Stilbenes | 2013 |
Novel strategies for preventing diabetes and obesity complications with natural polyphenols.
Topics: Adipocytes; Animals; Diabetes Mellitus; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Polyphenols; Resveratrol; Stilbenes | 2015 |
The role of phytochemicals as micronutrients in health and disease.
Topics: Cardiovascular Diseases; Catechin; Clinical Trials as Topic; Curcuma; Curcumin; Dementia; Diabetes Mellitus; Humans; Micronutrients; Neoplasms; Phytochemicals; Plant Extracts; Resveratrol; Stilbenes; Tea; Vitis; Wine | 2014 |
Resveratrol and diabetes: from animal to human studies.
Topics: Adipose Tissue; Animals; Diabetes Mellitus; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Liver; Muscle, Skeletal; Resveratrol; Stilbenes; Translational Research, Biomedical | 2015 |
Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets.
Topics: Animals; Antioxidants; Diabetes Mellitus; Diabetic Cardiomyopathies; Humans; Mitochondria; Myocardium; Resveratrol; Stilbenes | 2015 |
Application of resveratrol in diabetes: rationale, strategies and challenges.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antioxidants; Carbohydrate Metabolism; Cardiotonic Agents; Diabetes Mellitus; Enzyme Activation; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Insulin Resistance; Mice; Oxidative Stress; Rats; Resveratrol; Sirtuin 1; Stilbenes | 2015 |
The paradoxical pro- and antiangiogenic actions of resveratrol: therapeutic applications in cancer and diabetes.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Diabetes Mellitus; Dose-Response Relationship, Drug; Humans; Neoplasms; Resveratrol; Stilbenes | 2016 |
Antidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility.
Topics: Animals; Diabetes Mellitus; Humans; Hypoglycemic Agents; Resveratrol; Stilbenes | 2016 |
Sirtuins: novel targets for metabolic disease in drug development.
Topics: Animals; Antioxidants; Caloric Restriction; Diabetes Mellitus; Drug Design; Enzyme Activation; Humans; Insulin; Male; Mice; Rats; Resveratrol; Signal Transduction; Sirtuin 1; Sirtuins; Stilbenes; Substrate Specificity | 2008 |
Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease.
Topics: Animals; Coronary Disease; Diabetes Mellitus; Endothelial Cells; Glucose; Glucose Transporter Type 4; Heart; Humans; Hypercholesterolemia; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase Type III; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A | 2009 |
Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies.
Topics: Adiponectin; Animals; Anti-Inflammatory Agents; Anti-Obesity Agents; Antioxidants; Diabetes Mellitus; Ghrelin; Humans; Hypoglycemic Agents; Inflammation; Leptin; Obesity; Resveratrol; Stilbenes | 2010 |
Resveratrol, obesity and diabetes.
Topics: Animals; Diabetes Mellitus; Humans; Obesity; Resveratrol; Stilbenes | 2010 |
Anti-diabetic effects of resveratrol.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Resveratrol; Stilbenes | 2011 |
Resveratrol and health--a comprehensive review of human clinical trials.
Topics: Animals; Biological Availability; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Dietary Supplements; Humans; Liver; Obesity; Oxidative Stress; Resveratrol; Stilbenes; Wine | 2011 |
Caloric restriction and chronic inflammatory diseases.
Topics: Adaptive Immunity; Animals; Biomimetics; Caloric Restriction; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Insulin-Like Growth Factor I; Metformin; Periodontitis; Resveratrol; Signal Transduction; Sirolimus; Sirtuins; Stilbenes; TOR Serine-Threonine Kinases | 2012 |
Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential.
Topics: Cardiovascular Diseases; Cell Cycle; Chemoprevention; Chemotherapy, Adjuvant; Diabetes Mellitus; Gene Expression Regulation; Humans; Inflammation; Neoplasms; Neovascularization, Pathologic; Resveratrol; Signal Transduction; Stilbenes | 2007 |
2 trial(s) available for resveratrol and Diabetes Mellitus
| Article | Year |
|---|---|
Comparative Evaluation of Clinical Efficacy and Safety of Collagen Laminin-Based Dermal Matrix Combined With Resveratrol Microparticles (Dermalix) and Standard Wound Care for Diabetic Foot Ulcers.
Topics: Collagen; Diabetes Mellitus; Diabetic Foot; Humans; Laminin; Prospective Studies; Resveratrol; Treatment Outcome | 2021 |
Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.
Topics: Aged; Diabetes Mellitus; Drug Compounding; Endothelium, Vascular; Female; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Life Style; Male; Metabolic Syndrome; Middle Aged; Resveratrol; Stilbenes; Vasodilation; Vasodilator Agents | 2011 |
32 other study(ies) available for resveratrol and Diabetes Mellitus
| Article | Year |
|---|---|
Efficacy and safety of vitamin supplements with resveratrol in diabetic macular edema: Long-term results of a comparative study.
Topics: Angiogenesis Inhibitors; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Prospective Studies; Resveratrol; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Vitamins | 2022 |
Grafting resveratrol onto mesoporous silica nanoparticles towards efficient sustainable immunoregulation and insulin resistance alleviation for diabetic periodontitis therapy.
Topics: Diabetes Mellitus; Glucose; Humans; Insulin Resistance; Nanoparticles; Periodontitis; Resveratrol; Silicon Dioxide | 2022 |
Blocking of SGLT2 to Eliminate NADPH-Induced Oxidative Stress in Lenses of Animals with Fructose-Induced Diabetes Mellitus.
Topics: Animals; Cataract; Diabetes Mellitus; Fructose; Metformin; NADP; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Resveratrol; Sodium-Glucose Transporter 2 | 2022 |
Development and evaluation of Resveratrol-loaded liposomes in hydrogel-based wound dressing for diabetic foot ulcer.
Topics: Animals; Bandages; Diabetes Mellitus; Diabetic Foot; Hydrogels; Liposomes; Resveratrol | 2023 |
Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation.
Topics: Aldehyde Reductase; Diabetes Mellitus; Diabetic Nephropathies; Humans; Matrix Metalloproteinase 9; Molecular Docking Simulation; Network Pharmacology; PPAR gamma; Reproducibility of Results; Resveratrol | 2023 |
Resveratrol Alleviates Diabetic Periodontitis-Induced Alveolar Osteocyte Ferroptosis Possibly via Regulation of SLC7A11/GPX4.
Topics: Animals; Diabetes Mellitus; Ferroptosis; Glycation End Products, Advanced; Inflammation Mediators; Lipopolysaccharides; Male; Mice; Osteocytes; Periodontitis; Resveratrol | 2023 |
Elucidating shared biomarkers and pathways in kidney stones and diabetes: insights into novel therapeutic targets and the role of resveratrol.
Topics: Biomarkers; Diabetes Mellitus; Humans; Interleukin-11; Kidney Calculi; Male; Molecular Docking Simulation; Resveratrol | 2023 |
Resveratrol ameliorates diabetic encephalopathy through PDE4D/PKA/Drp1 signaling.
Topics: Animals; Diabetes Mellitus; Male; Mice; Resveratrol; Signal Transduction; Sulfonamides | 2023 |
A Mitochondrial Nanoguard Modulates Redox Homeostasis and Bioenergy Metabolism in Diabetic Peripheral Neuropathy.
Topics: Animals; Antioxidants; Diabetes Mellitus; Diabetic Neuropathies; Homeostasis; Mice; Mitochondria; Nucleic Acids; Oxidation-Reduction; Resveratrol | 2023 |
Mitochondria-Mediated Apoptosis Induced Testicular Dysfunction in Diabetic Rats: Ameliorative Effect of Resveratrol.
Topics: Animals; Apoptosis; Caspase 3; Caspase 9; Cytochromes c; Diabetes Mellitus; Humans; Hydrogen Peroxide; Male; Mitochondria; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Sperm Count; Spermatozoa; Testis | 2021 |
Effects of Physiological Doses of Resveratrol and Quercetin on Glucose Metabolism in Primary Myotubes.
Topics: Adult; AMP-Activated Protein Kinases; Diabetes Mellitus; Drug Evaluation, Preclinical; Fatty Acids; Glucose; Healthy Volunteers; Humans; Insulin Resistance; Lactic Acid; Male; Mitochondria; Muscle Fibers, Skeletal; Oxidation-Reduction; Phosphorylation; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Quercetin; Resveratrol; Signal Transduction | 2021 |
Anti-insulin resistance effect of constituents from Senna siamea on zebrafish model, its molecular docking, and structure-activity relationships.
Topics: alpha-Glucosidases; Animals; Anthraquinones; Diabetes Mellitus; Dipeptidyl Peptidase 4; Emodin; Hypoglycemic Agents; Insulin Resistance; Molecular Docking Simulation; Molecular Structure; Plant Extracts; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Resveratrol; Senna Plant; Stilbenes; Structure-Activity Relationship; Thailand; Wood; Zebrafish | 2021 |
Resveratrol ameliorates the glucose uptake and lipid metabolism in gestational diabetes mellitus mice and insulin-resistant adipocytes via miR-23a-3p/NOV axis.
Topics: Adipocytes; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes, Gestational; Diet, High-Fat; Disease Models, Animal; Female; Glucose; Insulin; Insulin Resistance; Lipid Metabolism; Mice; MicroRNAs; Nephroblastoma Overexpressed Protein; Pregnancy; Proto-Oncogene Proteins c-akt; Resveratrol; Wilms Tumor | 2021 |
Metabolites of flavonoid compounds preserve indices of endothelial cell nitric oxide bioavailability under glucotoxic conditions.
Topics: Antioxidants; Aorta; Biological Availability; Diabetes Mellitus; Diet; Endothelial Cells; Endothelium, Vascular; Flavonoids; Glucose; Humans; Insulin; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Plant Extracts; Proanthocyanidins; Proto-Oncogene Proteins c-akt; Quercetin; Resveratrol; Stilbenes | 2017 |
Effects of Resveratrol, Lovastatin and the mTOR-Inhibitor RAD-001 on Insulin-Induced Genomic Damage In Vitro.
Topics: Animals; Cell Survival; Cells, Cultured; Diabetes Mellitus; DNA Damage; Epithelial Cells; Everolimus; Humans; Insulin; Kidney; Lovastatin; Rats; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2017 |
Novel SIRT1 activator MHY2233 improves glucose tolerance and reduces hepatic lipid accumulation in db/db mice.
Topics: Acetyl-CoA Carboxylase; Animals; Benzoxazoles; Body Weight; Diabetes Mellitus; Enzyme Activators; Fatty Acid Synthases; Fatty Liver; Gene Expression Regulation; Glucose Intolerance; Heterocyclic Compounds, 4 or More Rings; Hypoglycemic Agents; Male; Metabolic Syndrome; Mice, Inbred C57BL; Molecular Docking Simulation; Resveratrol; Sirtuin 1; Sterol Regulatory Element Binding Proteins; Stilbenes | 2018 |
Nanoliposomal Resveratrol as a Novel Approach to Treatment of Diabetes Mellitus.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Drug Delivery Systems; Insulin; Liposomes; Nanoparticles; Oxidative Stress; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2018 |
Antioxidant and pro-oxidant actions of resveratrol on human serum albumin in the presence of toxic diabetes metabolites: Glyoxal and methyl-glyoxal.
Topics: Antioxidants; Diabetes Mellitus; Glyoxal; Humans; Oxidants; Oxidation-Reduction; Oxidative Stress; Protein Carbonylation; Pyruvaldehyde; Reactive Oxygen Species; Resveratrol; Serum Albumin, Human; Stilbenes | 2018 |
Isolation and characterization of resveratrol oligomers from the stem bark of Hopea ponga (Dennst.) Mabb. And their antidiabetic effect by modulation of digestive enzymes, protein glycation and glucose uptake in L6 myocytes.
Topics: Acetone; alpha-Amylases; alpha-Glucosidases; Animals; Cell Line; Diabetes Mellitus; Dipterocarpaceae; Enzyme Assays; Ethanol; Glycosylation; Hypoglycemic Agents; Inhibitory Concentration 50; Medicine, Traditional; Molecular Docking Simulation; Molecular Structure; Myoblasts; Plant Bark; Plant Extracts; Plant Stems; Rats; Resveratrol; Toxicity Tests | 2019 |
Anti-diabetic effects of trans-resveratrol byproducts induced by plasma treatment.
Topics: alpha-Amylases; alpha-Glucosidases; Antioxidants; Atmospheric Pressure; Diabetes Mellitus; Food Handling; Food Ingredients; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Methanol; Plasma Gases; Resveratrol | 2019 |
Resveratrol supplementation improves white adipose tissue function in a depot-specific manner in Zucker diabetic fatty rats.
Topics: Adipose Tissue, White; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Diabetes Mellitus; Dietary Supplements; Male; Obesity; Rats; Rats, Zucker; Resveratrol; Stilbenes; Treatment Outcome | 2013 |
Resveratrol attenuated smokeless tobacco-induced vascular and metabolic complications in ovariectomized rats.
Topics: Animals; Aorta; Collagen; Diabetes Complications; Diabetes Mellitus; Estradiol; Female; Glucose Tolerance Test; Insulin; Metabolic Diseases; Nitrates; Nitrites; Ovariectomy; Rats; Rats, Wistar; Resveratrol; Stilbenes; Tobacco, Smokeless; Vascular Diseases | 2013 |
Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-κB pathway.
Topics: Animals; Antigens, Differentiation; Blood Glucose; Chemokine CCL2; Diabetes Complications; Diabetes Mellitus; Inflammation; Intercellular Adhesion Molecule-1; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Resveratrol; Signal Transduction; Stilbenes; Vascular Cell Adhesion Molecule-1 | 2014 |
Resveratrol- and melatonin-abated ovariectomy and fructose diet-induced obesity and metabolic alterations in female rats.
Topics: Administration, Oral; Animals; Antioxidants; Diabetes Mellitus; Diet; Disease Models, Animal; Female; Fructose; Melatonin; Obesity; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2014 |
Effects of resveratrol on the expression and DNA methylation of cytokine genes in diabetic rat aortas.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Cytokines; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Angiopathies; DNA Methylation; Gene Expression Regulation; Humans; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Th1-Th2 Balance | 2014 |
Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Gene Expression Regulation; HEK293 Cells; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Nerve Net; Neurons; Niacinamide; Obesity; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Streptozocin | 2015 |
Sirt 1 activator inhibits the AGE-induced apoptosis and p53 acetylation in human vascular endothelial cells.
Topics: Acetylation; Apoptosis; Benzamides; Cardiovascular Diseases; Caspases; Cells, Cultured; Cytochromes c; Diabetes Mellitus; Endothelial Cells; Glycation End Products, Advanced; Humans; Insulin; Insulin Secretion; Naphthols; Oxidative Stress; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Tumor Suppressor Protein p53 | 2015 |
Stilbene glucoside from Polygonum multiflorum Thunb.: a novel natural inhibitor of advanced glycation end product formation by trapping of methylglyoxal.
Topics: Chromatography, Liquid; Diabetes Complications; Diabetes Mellitus; Glucosides; Glycation End Products, Advanced; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Molecular Conformation; Polygonum; Pyruvaldehyde; Resveratrol; Stilbenes | 2010 |
Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation.
Topics: Adenylate Kinase; Animals; Antioxidants; Atherosclerosis; Cholesterol; Diabetes Complications; Diabetes Mellitus; Glycation End Products, Advanced; Homeostasis; Humans; Lipid Metabolism; Macrophages; PPAR gamma; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Resveratrol; Stilbenes | 2010 |
The combination of bortezomib and resveratrol may prevent muscle wasting in diabetes.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Boronic Acids; Bortezomib; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Humans; Inflammation; Models, Biological; Muscular Atrophy; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Rats; Resveratrol; Stilbenes | 2011 |
Opposing actions of rosiglitazone and resveratrol on mineralization in human vascular smooth muscle cells.
Topics: Apoptosis; Atherosclerosis; Caspases; Cell Differentiation; Cells, Cultured; Diabetes Mellitus; Humans; Hypoglycemic Agents; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Resveratrol; Rosiglitazone; Signal Transduction; Stilbenes; Thiazolidinediones; Up-Regulation | 2011 |
Role of FoxO1 in FFA-induced oxidative stress in adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Nucleus; Diabetes Mellitus; Fatty Acids, Nonesterified; Forkhead Box Protein O1; Forkhead Transcription Factors; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Stilbenes | 2007 |